NCT07331454 is a Phase 3 clinical trial of Robotic Gastrectomy in Gastric Cancer (GC), sponsored by The First Affiliated Hospital with Nanjing Medical University.

Who is sponsoring NCT07331454?

NCT07331454 is sponsored by The First Affiliated Hospital with Nanjing Medical University.

What drugs are being tested in NCT07331454?

Interventions in NCT07331454: Robotic Gastrectomy, Laparoscopic Gastrectomy.

What condition does NCT07331454 study?

NCT07331454 studies Gastric Cancer (GC).

Is NCT07331454 still recruiting?

NCT07331454 is currently not yet recruiting. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT07331454

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer

Not yet recruiting Phase 3 Last updated 12 January 2026

What this trial tests

Phase 3 trial testing Robotic Gastrectomy in Gastric Cancer (GC) in 335 participants. Not yet recruiting.

Timeline

1 February 2026

Primary endpoint
31 December 2030

31 December 2031

Quick facts

Lead sponsor	The First Affiliated Hospital with Nanjing Medical University
Phase	Phase 3
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	335
Start date	1 February 2026
Primary completion	31 December 2030
Estimated completion	31 December 2031
Sites	1 location across China

Drugs / interventions tested

Robotic Gastrectomy
Laparoscopic Gastrectomy

Conditions studied

Gastric Cancer (GC) — all drugs for Gastric Cancer (GC) →

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Who can join

Adults 18 to 75, any sex, with Gastric Cancer (GC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this multicenter, randomized, phase III clinical trial is to test whether robot-assisted radical gastrectomy improves 3-year recurrence-free survival versus laparoscopy-assisted radical gastrectomy in adults aged 18-80 years with previously untreated, resectable cT4a gastric adenocarcinoma and non-bulky lymph nodes; the main questions are whether the robotic approach confers superior RFS and maintains equivalent peri-operative safety (Clavien-Dindo ≥ II complications) and better secondary oncologic outcomes, and participants will be randomized 1:1 to undergo standardized D2 resection via robotic or laparoscopic technique and followed for 5 years with scheduled recurrence, survival, and quality-of-life assessments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Robotic Gastrectomy

Trials testing the same drug.

NCT06791538 — Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer · NA · recruiting

Other recruiting trials for Gastric Cancer (GC)

Currently open trials in the same condition.

NCT07522320 — Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management · active not recruiting
NCT07311408 — SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure · Phase 2 · recruiting
NCT07366528 — Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer · Phase 3 · recruiting
NCT07313579 — Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer · recruiting
NCT07217704 — Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. · Phase 3 · recruiting

Other The First Affiliated Hospital with Nanjing Medical University trials

Trials by the same sponsor.

NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
NCT07523789 — Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC · not yet recruiting
NCT07464756 — SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer · Phase 2 · not yet recruiting
NCT07482826 — Full-Endoscopic Decompression vs. Endoscopic Lumbar Fusion for Middle-Aged and Older Adults With Spinal Stenosis · NA · not yet recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07331454 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital with Nanjing Medical University
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07331454.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing